Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2025-12-25 @ 9:15 PM
NCT ID: NCT02583256
Description: The overall safety set included all subjects who were in the solicited safety set and/or in the unsolicited safety set. Assessment of revaccination safety included: SAEs collected between Day 1 to Day 366 Non-serious AEs included solicited AEs collected between Day 1 to Day 7 after last vaccination, and unsolicited AEs collected between Day 1 to Day 366 after last vaccination
Frequency Threshold: 5
Time Frame: Day 1 - Day 366
Study: NCT02583256
Study Brief: Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine in Children Previously Vaccinated in Trial V118_05 (NCT01964989)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
aQIV-aQIV Subjects previously vaccinated with aQIV followed one year later by aQIV Adjuvanted QIV (aQIV): Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) 0 None 10 403 289 403 View
aQIV-QIV Subjects previously vaccinated with aQIV followed one year later by QIV Non-adjuvanted QIV: Non-adjuvanted Quadrivalent Influenza Vaccine (QIV) 0 None 11 403 269 403 View
QIV-aQIV Subjects previously vaccinated with QIV followed one year later by aQIV Adjuvanted QIV (aQIV): Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) 0 None 7 402 274 402 View
QIV-QIV Subjects previously vaccinated with QIV followed one year later by QIV Non-adjuvanted QIV: Non-adjuvanted Quadrivalent Influenza Vaccine (QIV) 0 None 8 393 229 393 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Iron Deficiency Anaemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA version 19.1 View
Lymphadenitis SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA version 19.1 View
Spina Bifida Occulta SYSTEMATIC_ASSESSMENT Congenital, familial and genetic disorders MedDRA version 19.1 View
Vertigo SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders MedDRA version 19.1 View
Aphthous Ulcer SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA version 19.1 View
Dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA version 19.1 View
Gastritis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA version 19.1 View
Anaphylactic Reaction SYSTEMATIC_ASSESSMENT Immune system disorders MedDRA version 19.1 View
Amoebic Dysentery SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA version 19.1 View
Appendiceal Abscess SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA version 19.1 View
Bronchitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA version 19.1 View
Dengue Fever SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA version 19.1 View
External Ear Cellulitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA version 19.1 View
Gastroenteritis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA version 19.1 View
Herpangina SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA version 19.1 View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA version 19.1 View
Respiratory Tract Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA version 19.1 View
Tonsillitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA version 19.1 View
Urinary Tract Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA version 19.1 View
Animal Bite SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA version 19.1 View
Fall SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA version 19.1 View
Jaw Fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA version 19.1 View
Wound Secretion SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA version 19.1 View
Febrile Convulsion SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA version 19.1 View
Kawasaki's Disease SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA version 19.1 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA version 19.1 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA version 19.1 View
Influenza Like Illness SYSTEMATIC_ASSESSMENT General disorders MedDRA version 19.1 View
Injection Site Erythema SYSTEMATIC_ASSESSMENT General disorders MedDRA version 19.1 View
Injection Site Induration SYSTEMATIC_ASSESSMENT General disorders MedDRA version 19.1 View
Injection Site Pain SYSTEMATIC_ASSESSMENT General disorders MedDRA version 19.1 View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders MedDRA version 19.1 View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA version 19.1 View
Upper Respiratory Tract Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA version 19.1 View
Somnolence SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA version 19.1 View
Eating Disorder SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA version 19.1 View
Irritability SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA version 19.1 View